CNX
67
4
CLX
65
2
EMC
30
-26
TXT
46
4
JPM
59
6
ORCL
49
3
ILMN
31
4
NWS
69
5
PNC
48
6
MAR
57
3
HP
44
14
AMAT
33
3
ETN
64
4
CF
47
5
AEP
45
5
BXP
39
5
VFC
56
6
GM
55
6
HOG
29
4
SYK
50
4
CNX
67
4
CLX
65
2
EMC
30
-26
TXT
46
4
JPM
59
6
ORCL
49
3
ILMN
31
4
NWS
69
5
PNC
48
6
MAR
57
3
HP
44
14
AMAT
33
3
ETN
64
4
CF
47
5
AEP
45
5
BXP
39
5
VFC
56
6
GM
55
6
HOG
29
4
SYK
50
4
Financhill
Back

Stoke Therapeutics 10K Form

Sell
27

STOK
Stoke Therapeutics

Last Price:
$11.68
Seasonality Move:
1.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive STOK News And Ratings

See the #1 stock for the next 7 days that we like better than STOK

STOK Financial Statistics

Sales & Book Value

Annual Sales: $8.8M
Cash Flow: $-21.7M
Price / Cash Flow: 0
Annual Sales: $4.38
Price / Book: 2.67

Profitability

EPS (TTM): -2.10000
Net Income (TTM): $-105.5M
Gross Margin: --
Return on Equity: -55.64%
Return on Assets: -41.37%

Stoke Therapeutics Earnings Forecast

Key Stoke Therapeutics Financial Ratios

  • The Research & Development expenses have been 936.57% of Revenue.
  • The Net Earning history of STOK is -1,192.47% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Stoke Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: STOK
CUSIP: 86150R
Website: stoketherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

STOK Technical Analysis vs Fundamental Analysis

Sell
27
Stoke Therapeutics (STOK) is a Sell

Is Stoke Therapeutics a Buy or a Sell?